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GlycolysisBioenergetic proﬁling of tumors is a new challenge of cancer research andmedicine as therapies are currently
being developed. Meanwhile, methodological means must be proposed to gather information on tumor me-
tabolism in order to adapt these potential therapies to the bioenergetic speciﬁcities of tumors. Studies
performed on tumors and cancer cell lines have shown that cancer cells bioenergetics is highly variable.
This proﬁle changes with microenvironmental conditions (eg. substrate availability), the oncogenes activated
(and the tumor suppressors inactivated) and the interaction with the stroma (i.e. reverse Warburg effect).
Here, we assessed the power of metabolic footprinting (MFP) to unravel the bioenergetics and associated an-
abolic changes induced by three oncogenes, c-Myc, KLF4 and Oct1. The MFP approach provides a quantitative
analysis of the metabolites secreted and consumed by cancer cells. We used ultra performance liquid
chromatography for quantifying the amino acid uptake and secretion. To investigate the potential
oncogene-mediated alterations in mitochondrial metabolism, we measured oxygen consumption rate and
ATP production as well as the glucose uptake and lactate release. Our ﬁndings show that c-Myc deﬁciency
initiates the Warburg effect along with a reduction of mitochondrial respiration. KLF4 deﬁciency also stimu-
lated glycolysis, albeit without cellular respiration impairment. In contrast, Oct1 deﬁciency reduced glycoly-
sis and enhanced oxidative phosphorylation efﬁciency. MFP revealed that c-Myc, KLF4 and Oct1 altered
amino acid metabolism with speciﬁc patterns. We identiﬁed isoleucine, α-aminoadipic acid and GABA
(γ-aminoisobutyric acid) as biomarkers related. Our ﬁndings establish the impact of Oct1, KLF4 and c-Myc
on cancer bioenergetics and evidence a link between oncosecretomics and cellular bioenergetics proﬁle.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
In the last decade, metabolic studies have revealed the existence of a
large number of deregulations of the metabolic pathways involved in
cancer cell's energy production, anabolism and tumor survival. For in-
stance, cancer speciﬁc molecular changes were described at the level
of hexokinase II (HK2), pyruvate dehydrogenase kinase 1 (PDK1), pyru-
vate dehydrogenase (PDH), isocitrate dehydrogenase (IDH1/2), ATP cit-
rate lyase and lactate dehydrogenase isoforms (LDH) (see [1] and [2] for
review). Three different metabolic remodeling have been reported in
cancer cells based on the imbalance between the aerobic glycolysis
and the oxidative phosphorylation. The phenotypes described were
“highly glycolytic”, “OXPHOS deﬁcient” and “OXPHOS enhanced”.and Biomolecular Engineering,
St, Houston, TX, 77251-1892,
h).
l rights reserved.These studies raised the question of the variability of cancer cell's bioen-
ergetic proﬁle and suggested to investigate further the variable modal-
ities of energy production in tumors. This is a pre-requisite to select
adapted tentative bioenergetics therapies targeted against the primary
pathways of energy production and/or against the cancer-speciﬁc devi-
ations of catabolism toward anabolism. The characterization of tumor
bioenergetics proﬁle necessitates tumor excision and both molecular
and functional analyses in a microenvironment that mimics the tumor
milieu. Moreover, as cancer cells express several oncogenes and since
they grow in variablemicroenvironments, the complexity of cell's ener-
getics is difﬁcult to assess from the singlemeasurements of ATP produc-
tion by glycolysis and by oxidative phosphorylation in a chosen growth
medium. Therefore, non-invasive technique should be developed in
combination with bioenergetics proﬁling to better characterize tumor
metabolism.
There is a need for alternative methodological means that could
allow to derive relevant information on cancer energetics on a large
number of samples. To this aim, we assessed here the potency of
2061N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071metabolic footprinting (MFP), a high throughput method for evaluat-
ing the metabolic changes that occur in the cellular secretome follow-
ing the activation of speciﬁc oncogenes: c-Myc, KLF4 and Oct1 [3].
Whether speciﬁc changes in the tumor secretome, could provide a
signature of particular oncogenes activation and of associated meta-
bolic remodeling remains unknown. MFP is a powerful approach
which helped recently to identify biomarkers predictive of diabetes
[4]. We focused on the amino acids to gather information on the im-
pact of c-Myc, Oct1 and KLF4 on the equilibrium between catabolism
and anabolism. Recent studies revealed that carcinogenesis alters this
equilibrium in favor of amino acid and lipid synthesis from glycolysis
intermediates and TCA cycle metabolites, respectively [5]. Prior anal-
ysis of the metabolomics of prostate cancer or even colorectal cancer
revealed important changes in amino acids [5,6]. However, the bioen-
ergetic signiﬁcance of these changes was not assessed. Furthermore,
oncosecretomics could potentially help to identify the changes that
occur at the level of energy metabolism in metabolic diseases other
than cancer. Here we assessed in parallel the composition changes
in the secreted metabolites and the deviations of energy production
induced by oncogenes to assess the predictive potential of MFP.
2. Materials and methods
2.1. Cell types and culture conditions
The TGR-1 (c-Myc+/+), HO15 (c-Myc−/−) and HOMYC (HO15+
c-Myc) cells are rat ﬁbroblasts and were obtained from Dr John Sedivy
[7]. The wild-type mouse embryonic ﬁbroblasts (MEFs) and Oct1−/−
MEFs were obtained from Dr Dean Tantin [8]. The wild-type KLF4,
KLF4+/− and KLF4−/− MEFs were provided by Dr Vincent Yang [9]. All
cells were cultured in Dulbecco's modiﬁed eagle medium (DMEM) high
glucose (GIBCO) containing 25 mM glucose, supplemented with 10%
fetal calf serum (Invitrogen), 100 U/ml penicillin and streptomycin. All
cells were kept in 5% CO2 at 37 °C.
2.2. Cell proliferation
The cells were seeded at 104 cells per well in several 12 well
plates. Cells were collected after every 24 h until 5 days. The collected
cells were treated with 0.2% trypan blue in order to determine the vi-
able cell number in each well.
2.3. Metabolic assays
The pyruvate uptakewas estimated spectrophotometrically bymea-
suring the remaining pyruvate in growthmedia after 24 h of incubation
of the cells in different experimental conditions as speciﬁed in the text.
The principle of the assay was to determine the amount of NADH oxi-
dized at 340 nmon 96well plates. Eachwell contained 20 μL of sample,
NADH reagent, and lactate dehydrogenase reconstituted at 50% in glyc-
erol and dilute at 1:20 in Tris (0.1 M, pH 7). After the incubation time,
the cells were collected and lysed for protein determination (Pierce
BCA Protein Assay kit). The results were then expressed in μmol/μg of
protein as mean±S.E.M. The lactate secretion was quantiﬁed with the
lactate kit (Trinity biotech). The lactate secreted into the growth
media by the cells after 24 h of incubation was measured according to
themanufacturer's instructions. The absorbance at 540 nmwas propor-
tional to the lactate concentration in the sample. The results were
expressed in μmol/μg of protein. By a similar method, the glucose con-
sumption was determined with the Glucose Autokit (Wako).
2.4. ATP measurements
The intracellular ATP content was measured for the different cell
types using the Cell Titer-Glo Luminescent cell viability assay
(Promega). The cells were seeded in 96 well plates at 2.104 cells perwell in 200 μL of high glucose DMEM medium. The following day,
the media was replaced with 100 μL of high glucose DMEM without
phenol red. The cells were then incubated for 1 h in either, the ab-
sence or the presence of oligomycin (2 μg/ml), 2-deoxyglucose
(100 mM), or oligomycin plus 2-deoxyglucose, at 37 °C. The ATP con-
tent was thereby measured according to the manufacturer's instruc-
tions, with a spectrophotometer SpectraMax M5 (Molecular Devices).
2.5. Live/dead viability/cytotoxicity assay
The effect of 2DG on cell viability was quantiﬁed using the Live/
Dead Viability/Cytotoxicity kit (Invitrogen). All the cells were seeded
in 96 well plates at the same density as was done for the ATP mea-
surements (2.104 cells per well). After an overnight incubation, cells
were incubated in either 100 μL of DMEM high glucose, 100 mM
2DG or methanol (70%) for 1 h at 37 °C. At the end of the incubation
time, cells were washed with PBS and treated with 0.5 μM Calcein AM
and 1 μM Ethidium homodimer-1 for 30 min at 37 °C. Next, ﬂuores-
cence was read at 517 nm for the live cells after an excitation of
calcein AM at 494 nm. The amount of dead cells was determined by
measuring the ﬂuorescence emission at 617 nm produced via the ex-
citation of ethidium homodimer-1 at 528 nm.
2.6. XF bioenergetic assay
Mitochondrial oxygen consumption was monitored with an XF24
Extracellular ﬂux Analyzer (Seahorse Bioscience). The cells were seeded
in Seahorse 24 well microplates at a cell density of 104 cells per well
in 100 μL of assay media. The following day, after an overnight incuba-
tion at 37 °C with 5% CO2, the cells were washed with PBS and then
incubated in 200 μL of either high glucose DMEM for 24 h. For equili-
bration, the media was replaced with 850 μL of assay medium com-
posed of high glucose DMEM medium (25 mM glucose, 4 mM
glutamine and 1 mM pyruvate, without serum and sodium bicarbon-
ate) and incubated at 37 °Cwithout CO2 for 1 h. The endogenous respi-
ration or basal oxygen consumption rate (OCR)was thenmeasured. The
endogenous coupling degree of the OXPHOS systemwas assessed using
oligomycin (2 μg/ml), an inhibitor of the F1FO-ATPsynthase. The
uncoupled OCRwas alsomeasured in presence of 2.5 μMof FCCP. Final-
ly, the cells were treated with a mitochondrial complex III inhibitor,
antimycin A in order to assess the mitochondrial contribution to OCR.
2.7. Western blot
Cell lysis was performed using 4% laurylmaltoside as a detergent
with each cell suspensions containing PBS and protease inhibitors
(PMSF, Pepstatin A and Leupeptin). Antibodies against the respiratory
chain complexes were obtained from Mitosciences. The anti β-actin,
anti-GLUT1 and anti-ASCT2 antibodies were purchased from SantaCruz
Biotechnology. The signal was detected using the chemiluminescent ECL
PlusTM reagent (Amersham), and subsequently quantiﬁed with densi-
tometric analysis using Image J software (NIH).
2.8. UPLC
Media samples were collected after 24 h of incubation and were
stored at −80 °C. Extracellular metabolite proﬁling was performed
using a Waters ACQUITY UPLC system. Each media sample was pre-
pared according to the manufacturer's instructions. Chromatographic
separations were performed on a 2.1×150 mm chromatography col-
umn. The column was maintained at 43 °C, eluted with a mix of 99.9%
of MassTrak AAA eluent A concentrate (8–10% acetonitrile, 4–6%
formic acid, 84–88% ammonium acetate/water solution), and diluted
at 10% in miliQ water and 0.1% of MassTrak AAA eluent B (≥95% ace-
tonitrile, ≤5% acetic acid) with a ﬂow rate of 0.4 ml/min. 1 μL of
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with UV detection at 260 nm.2.9. Statistical analysis
The results presented are expressed in mean value of N experi-
ments±S.EM, with N≥3. Comparison of the data sets obtained
from the different experiment conditions was performed with the
Student t test. Differences were considered to be statistically signiﬁ-
cant when P values were ≤0.05.
The uptake and secretion of amino acid measured on cells ex-
pressing or deﬁcient for c-Myc, Oct1 and KLF4, were compared with
partial least squares analysis (PLS) for statistical discrimination.Fig. 1. Secretomics of ﬁbroblasts in culture. The cell metabolism was measured at different asp
amino acids uptake and releasewas quantiﬁedwith the glucose and pyruvate consumptions, as
ASCT2were also investigated. The glycolytic andmitochondrial contributions to ATP production
of the amino acids standard solution was obtained by UPLC (B). The speciﬁc retention times are
nia; PEA, phosphoethanolamine; Asn, Asparagine; 3MH, 3-methylhistidine; Tau, taurine; 1MH,
Ans, Anserine; EA, ethanolamine; Asp: Aspartic acid; Sar, sarcosine; Glu, glutamate; Cit, citrul
α-aminoadipic acid; Pro, proline; BAIB, β-aminoisobutyric acid; Hyl1, hydroxylysine 1; Hyl2, h
cystine; Lys, lysine; Tyr, tyrosine; Met, methionine; Val, valine; Nva, norvaline; Ile, isoleucine; A
Norvaline was added in the different media samples as an internal standard.3. Results
Bioenergetic reprogramming impacts the main pathways of ener-
gy production such as glycolysis and oxidative phosphorylation in
most cancer cells. These two pathways are linked with amino acid
consumption and synthesis, so that the follow-up of amino acid is in-
timately linked to energy metabolism, as illustrated in Fig. 1A. To
study this link, we investigated the impact of three oncogenes on
both energy and amino acid metabolism (Fig. 1B). The effect of each
oncogene's expression inhibition on cellular proliferation was investi-
gated in Fig. 2. As expected, c-Myc deﬁcient cells had signiﬁcantly re-
duced proliferation rate when compared to c-Myc proﬁcient TGR-1
cells. The c-Myc re-expressing HOMYC cells had a higher proliferation
rate as compared to the HO15 cells. Thus, we can conclude thatects regarding extracellular metabolites in the wild-type and deﬁcient cell lines (A). The
well as the lactate secretion. The expression of glucose GLUT1 and glutamine transporters
were analyzed. And the oxygen consumption rates were determined. The chromatogram
indicated for eachmetabolite: Pser, phosphoserine; HyPro, hydroxyproline; NH3, Ammo-
1-methylhistidine; Ser, serine; Gln, glutamine; Carn, carnosine; Arg, arginine; Gly, glycine;
line; B-ala, β-alanine; Thr, threonine; Ala, alanine; GABA, γ-amino-N-butyric acid; AADA,
ydroxylysine 2; AABA, α-amino-N-butyric acid; Cyst, Cystathionine; Orn, Ornithine; Cys,
lle, allo-isoleucine; Leu, leucine; Hcys, homocystine; Phe, phenylalanine; Trp, tryptophan.
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(Fig. 2A) as shown in previous studies [10,11]. We noticed that prolif-
eration rate of KLF4 −/−was marginally higher compared to the KLF4
wild-type cells after 4 days of culture (Fig. 2B). On the other hand, no
signiﬁcant difference was observed for the proliferation rate between
wild-type and Oct1−/− MEFs (Fig. 2C).Fig. 2. c-Myc and KLF4 expression inhibition differentially regulates cell proliferation.
The effect of c-Myc (A), KLF4 (B) and Oct1 (C) expression on cell proliferation was
measured on days 1, 2, 3, 4, and 5. The numbers of live cells were counted using trypan
blue (0.2%) dye exclusion method for each time point. The growth curve for each cell
type is combination of three independent experiments performed in triplicate. Here,
cell numbers are shown as mean±S.E.M.3.1. Effect of c-Myc on metabolomics and bioenergetics
We ﬁrst analyzed c-Myc induced changes in cell metabolism. We
compared the glucose uptake in c-Myc proﬁcient ﬁbroblasts (TGR-1
and HOMYC) and c-Myc deﬁcient cells (HO15) over 24 h of growth
in high glucose DMEM. c-Myc deﬁcient HO15 cells showed a twice
higher glucose consumption compared to the c-Myc expressing
TGR-1 (0.0967±0.0132 versus 0.0697±0.00437 μmol/μg of protein,
Pb0.05) or to the HOMYC cells (0.0766±0.0214 μmol/μg of protein)
(Fig. 3A). These results indicate that c-Myc negatively controls glu-
cose consumption as previously shown in other cell types [12,13].
High glycolysis is typically associated with lactic acidosis, so we mea-
sured the concentration of excreted lactate to verify the potential oc-
currence of the Warbug effect. As expected, the amount of lactate
secreted by the c-Myc deﬁcient HO15 cells was higher as compared
to TGR-1 cells (0.0134±0.00099 versus 0.0093±0.00027 μmol/μg
of protein, Pb0.001). This metabolic disturbance was rescued by the
recovery of c-Myc activity as the quantity of lactate released in the in-
cubation medium by the c-Myc re-expressing HOMYC cells was lower
than in the HO15 cells with P=0.0001 (Fig. 3B). To investigate the
mechanisms underlying the non-complete oxidation of glucose, we
evaluated the capacity of the cells to oxidize pyruvate via oxidative
phosphorylation. We observed a lower pyruvate uptake (Fig. 3C) in
HO15 cells compared to the TGR-1 cells (0.0041±0.00033 and
0.0066±0.00061 μmol/μg of protein respectively, Pb0.01). Taken to-
gether, these results indicate that c-Myc deﬁcient cells present the
Warburg effect and derive energy primarily from high glycolysis rath-
er than OXPHOS.
To evaluate the impact of c-Myc inactivation on mitochondrial
function, we measured the oxygen consumption rate (OCR) in HO15
cells and controls using the XF24 Seahorse analyzer. As seen in
Fig. 3D, the baseline OCR measured in HO15 cells was signiﬁcantly
lower than in c-Myc proﬁcient TGR-1 cells (27.67±4.42 pmol/min
versus 67±12.72 respectively, Pb0.05). To assess the full capacity
of the respiratory chain, we used 2.5 μM FCCP to uncouple OXPHOS.
As expected, uncoupled respiration was strongly reduced in the
HO15 cells (39.89±5.18 pmol/min) as compared to the TGR-1 cells
(103.71±21.39 pmol/min). Inhibition of the mitochondrial phos-
phorylation system with 2 μg/mL oligomycin allowed to calculate
the respiratory control ratio (RCR) which gives a measure of the mi-
tochondrial respiration for ATP synthesis. As seen in Fig. 3E, HO15
cells presented with a low RCR value (2.23±0.28) as compared to
TGR-1 cells (3.98±0.66). Lastly, the rescue of c-Myc expression in
HOMYC cells reset the coupling ratio to normal values (4.30±0.96,
Pb0.05 versus the c-Myc deﬁcient cells RCR of 2.23). However,
c-Myc reactivation in HO15 cells could not recover the uncoupled
OCR, suggesting that irreversible changes had occurred in the
OXPHOS system of c-Myc deﬁcient cells.
To fully characterize the bioenergetic changes induced by c-Myc
deﬁciency, we measured the steady-state ATP production and
determined the relative contribution of OXPHOS to cellular ATP syn-
thesis by performing the inhibition of the F1F0-ATPsynthase with
oligomycin as previously described [14]. As seen in Fig. 3F, the ATP
production in presence of oligomycin was unchanged in HO15 cells
in (100.74±2.14% of the untreated HO15), as compared to the
TGR-1 controls where a reduction was observed (86.43±2.89% of
the untreated TGR-1).
To understand the c-Myc deﬁciency induced mitochondrial
changes, we measured the protein content of several respiratory
chain complexes sub-units (Fig. 4). We noticed a lower expression
level of CI20 in HO15 and HOMYC than in TGR-1 cells. However, the
c-Myc deﬁcient cells presented no signiﬁcant difference in the other
OXPHOS protein expression level when compared to the both c-Myc
expressing cells. The higher glucose uptake measured in the c-Myc
deﬁcient cells was explained by a higher expression of GLUT1 in
HO15 cells as compared to TGR-1 and HOMYC (Fig. 4). Furthermore,
Fig. 3. Effect of c-Myc expression on the glycolytic substrates consumption, mitochondrial respiration and energy production. The glucose consumption (A), the lactate secretion (B) and
the pyruvate uptake (C) were measured in rat ﬁbroblasts. Each metabolite was measured after 24 h of incubation in high glucose DMEM (25 mM glucose) as growth media. The
corresponding cell pellets were used for quantifying the protein content for normalization. The results are expressed in μmol/μg protein as mean±S.E.M for the glucose, lactate and py-
ruvate content (*, Pb0.05; **, Pb0.01 and ***, Pb0.001). The oxygen consumption rate (OCR) has beenmeasured in high glucose DMEM (HG, 25 mM glucose, 1 mM pyruvate and 4 mM
glutamine) under endogenous condition or in the presence of FCCP (2.5 μM)on the TGR-1, HO15 andHOMYC cells (D) The OCR values expressed in pmol/min representmeans±S.E.M (*,
Pb0.05). The RCR has also been determined by calculating the ratio of baseline OCR on the respiration in presence of 2 μg/ml oligomycin (E). Then the quantity of ATP produced by TGR-1,
HO15 and HOMYC cells (F) were determined in DMEM HG medium in presence of oligomycin (2.5 μg/μl) and/or 2DG (100 mM). Data is expressed for each cell type in percent of ATP
content without inhibitor as the mean±S.E.M (*, Pb0.05; **, Pb0.01 and ***, Pb0.001).
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TGR-1 and HOMYC cells conﬁrmed the enhancement of glycolysis in
c-Myc expressing cells.
To study the impact of c-Myc on amino acids metabolism, we an-
alyzed the uptake/secretion of 40 amino acids in these cells after 24 h
of incubation in high glucose DMEM (Fig. 5A and B). We noticed that
branched-chain amino acids (BCAA) uptake such as Isoleucine, leu-
cine and valine, were reduced (greater than two folds, Pb0.05) in
c-Myc deﬁcient HO15 cells, as compared to c-Myc proﬁcient TGR-1
cells. MFP also revealed an increase in the uptake of the ketogenic
amino acid lysine in HO15 cells as compared to TGR-1 and HOMYC
cells (2.72 and 1.98 as fold change, respectively, Pb0.05). We further
observed signiﬁcant change in the level of taurine, which was secret-
ed by the cells expressing c-Myc (TGR-1 and HOMYC) but consumed
from the medium by c-Myc deﬁcient HO15 cells. There was also a sig-
niﬁcant increase in alanine secretion in the c-Myc proﬁcient cells
(1.61 and 1.56 fold change in TGR-1 cells and HOMYC respectively,
Pb0.05, relative to HO15 cells). Interestingly, we detected that the
uptake ﬂux of citrulline, an amino acid involved in urea cycle, was sig-
niﬁcantly upregulated in HO15 cells compared to that in HOMYC.
Furthermore, we noticed that the uptake ﬂux of 4-aminobutyrate
(GABA), a neurotransmitter, was also signiﬁcantly increased in
HO15 cells as compared to TGR-1 and HOMYC cells. Lastly, the secre-
tion of ethanolamine (EA), an amino acid involved in phospholipids
synthesis, was dramatically increased (greater than eight fold) in
HO15 cells compared to TGR-1. The cystine uptake ﬂux was remark-
ably increased and its precursor cystathionine secretion was reduced
in HO15 cells compared to TGR-1 cells. These ﬁndings indicate that
c-Myc not only modulates glutamine metabolism [15] but also
impacts the catabolism and the synthesis of other amino acids. We
illustrated the simpliﬁed amino acids secretomics proﬁle of c-Myc
deﬁcient cells (changes greater than 1.5) in supplemental data.3.2. Effect of KLF4 on metabolomics and bioenergetics
To examine the inﬂuence KLF4 on cell metabolism, we performed
the same approach as for c-Myc. Both glucose uptake and lactate se-
cretion were signiﬁcantly higher in KLF4−/− cells than in the KLF4
wild-type (factor of 3.81 for the glucose consumption and of 1.36
for the lactate secretion) (Fig. 6A and B). Thus, KLF4 expression
seems to be inversely correlated with the glycolytic phenotype, as
for c-Myc. The decline in KLF4 expression during the exponential
phase of proliferation could explain the enhancement of glycolysis
phenotype obtained with the KLF4−/− cells. This proﬁle is in accor-
dance with the Warburg effect observed in highly proliferative
cancer cells. Lastly, we observed a lower pyruvate uptake (Fig. 6C)
in KLF4−/− cells compared to the KLF4 +/− cells.
To investigate the impact of KLF4 on mitochondrial metabolism,
we measured the OCR (Fig. 6D). Interestingly, KLF4 wild-type,
KLF4+/− and KLF4−/− cells had similar endogenous respiration
(around 109.20±6.71 pmol/min for the wild-type, 128.44±26.06
for the KLF4+/− and 101±5.28 pmol/min for the KLF4−/− cells).
Furthermore, the inhibition of KLF4 expression had no impact on
the RCR (2.59±0.36, 2.85±0.25 and 2.36±0.17 for the KLF4
wild-type, KLF4+/− and, KLF4−/− respectively), indicating that KLF4
has no regulatory effect on mitochondrial respiration (Fig. 6E). We
next assessed the impact of KLF4 on ATP production (Fig. 6F). The in-
hibition of ATP production with 2-deoxy-D-glucose (2DG) reﬂected
the contribution of glycolysis. To verify that the changes induced by
2DGwere not related to the possible induction of cell death, we quan-
tiﬁed the amount of live and dead cells in the experimental conditions
used for ATP measurements (supplemental Fig. 1). We noticed no ac-
tivation of cell death so that the observed decrease of ATP content
triggered by 100 mM 2DG was not the consequence of cell death. In
addition, the ATP content measured in the presence of 2DG indicated
Fig. 4. Expression of mitochondrial protein in TGR-1, HO15 and HOMYC cells. The OXPHOS complexes and glycolytic enzyme PKM2 expression level were quantiﬁed by western blot
on cell lysate prepared from TGR-1, HO15 and HOMYC (A). The results are expressed in band density ratios of mitochondrial (B) or glycolytic protein PKM2 (C) on β-actin as
mean±SD (*, Pb0.05). The expression of c-Myc, GLUT1 and ASCT2 expression level were quantiﬁed by western blot, on cell lysate of TGR-1, HO15 and HOMYC cells (D).
2065N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071that glycolysis provided energy to a greater extend in KLF4 +/− and
KLF4 −/− when compared to the KLF4 +/+ cells (39.20±3.39% for
the KLF4−/− , 37.57±2.12% for the KLF4+/− and 45.15±2.78% for
the KLF4 wild-type). The treatment of these cells with oligomycin
conﬁrmed these ﬁndings as this drug had minor effect on the ATP
levels (92.30±3.54 for KLF4+/+, 97.79±10.09% for the KLF4+/−
and 93.36±5.49% for the KLF4−/− cells). These results also revealed
that KLF4 had little impact on the contribution of mitochondria to cel-
lular ATP synthesis.
To investigate the role of KLF4 in both the uptake and release of
amino acid, we performed UPLC analysis of the spent media after
24 h of incubation. The detailed amino acid amounts are shown in
supplemental Table 2. The uptake of valine was signiﬁcantly higher
in KLF4 WT cells compared to that in KLF4−/− cells (Fig. 7). As wasobserved with the measurement of glycolysis, we noticed a signiﬁ-
cant increase (thirty-eight folds increase) in secretion of glucogenic
amino acid aspartate in KLF4 WT cells compared to KLF4−/− cells.
There was a remarkable reduction in glutamine uptake in KLF4 WT
cells compared to that in KLF4−/− cells. Moreover, the uptake of phe-
nylalanine and tyrosine were increased in the KLF4−/− cells com-
pared with the wild-type (1.99 fold change of phenylalanine; 1.66
fold change of tyrosine). These amino acids are involved in the
formation of fumarate which serves to fuel the Krebs cycle and subse-
quent respiratory chain. The secretion of ethanolamine, sarcosine,
and β‐alanine were signiﬁcantly increased in KLF4WT cells compared
to that in KLF4−/− cells. The uptake of ornithine, citrulline, and
1-methyl histidine, were increased in KLF4 WT cells compared to
that in KLF4−/− cells. We observed that uptake of lysine, a ketogenic
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Fig. 5. Effect of c-Myc expression on the metabolomics. The amino acid secretion and up-
take were measured on the cells c-Myc deﬁcient (HO15) and the one expressing c-Myc
(TGR-1 and HOMYC) after 24 hour incubation. The results are expressed in fold changes
relative to HO15 for c-Myc proﬁcient TGR-1 (A) and HOMYC (B) (*, Pb0.05; **, Pb0.01
and Pb0.001).
2066 N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071amino acid was upregulated in KLF4−/− cells compared to that in
wild-type cells. Notably, secretion of amino acids involved in urea
cycle, such as asparagine and arginine; formation of α-ketoglutarate
(proline, arginine and histidine), formation of pyruvate (alanine and
glycine), and formation of TCA cycle substrates (hydroxylysine 1)
was upregulated in KLF4−/− cells compared to that in wild-type
cells. We observed an inversion in serine and cystine contents. They
were consumed in KLF4 deﬁcient cells but secreted in the wild-type.
We found a similar behavior with hydroxyproline, which was secreted
in thewild-type cells (0.00011±0.000021 μmol/μg protein) in contrast
to KLF4−/− cells where it was uptaken (0.000125±0.0000495 μmol/μg
protein). Interestingly, secretion of α-aminoadipic acid (amino acid
involved in synthesis of lysine and acetyl-CoA), β-aminoisobutyric
acid (product of thymine metabolism), and phosphoethanolamine
(involved in phospholipid metabolism) were remarkably increased in
KLF4−/− cells compared to the wild-type cells. KLF4 seems to be
involved in antioxidant pathways with the anserine uptake and
the carnosine secretion increased in KLF4−/− cells as compared to
wild-type cells. These observations suggest that KLF4 is not only
involved in inhibiting glycolysis but also regulates phospholipid
metabolism, nitrogen balance, and DNA and RNA metabolism.3.3. Effect of Oct1 on metabolomics and bioenergetics
To assess the impact of Oct1 deﬁciency on energy metabolism, we
analyzed glucose and pyruvate uptake as well as lactate secretion in
wild-type and Oct1−/− MEFs. We observed that the inhibition of Oct1
expression induced a signiﬁcant decrease in glucose consumption
(0.135±0.042 μmol/μg of protein) as compared to the wild-type
MEFs (0.283±0.051 μmol/μg of protein, Pb0.05) in high glucose medi-
um (Fig. 8A). Accordingly, the amount of lactate released by Oct1−/−
cells was lower than their wild type counterparts (factor 1.9) in high
glucose medium (Fig. 8B). Oct1−/− cells displayed a poor utilization of
pyruvate suggesting an involvement of Oct1 in the regulation of pyru-
vate uptake and/or oxidation (0.015±0.0036 in MEF wild-type and
0.0045±0.00135 μmol/μg protein in the MEF Oct1 −/− (Fig. 8C).
To assess the possible role of Oct1 in the regulation of mitochon-
drial respiration, we measured the baseline OCR and RCR. There was
no signiﬁcant difference between the baseline OCR in MEF
wild-type (104.25±10.65 pmol/min) and the MEF Oct1 deﬁcient
cells (114.77±9.70 pmol/min) (Fig. 8D). However, the inhibition of
Oct1 expression provided a better RCR (3.16±0.23 for the MEF
Oct1−/− and 2.41±0.20 for the wild-type) (Fig. 8E). This coupling
ratio is explained by the energy production process. As seen in
Fig. 8F, the Oct1−/− MEFs cells exhibited a lower ATP content than
(90±3.88%) the wild-type MEF cells (101.74±5.71%) in the pres-
ence of oligomycin. The increase in ATP production observed after
1 h of incubation in the presence of oligomycin suggested that the
cells were able to stimulate glycolysis in order to compensate for
the inhibition of mitochondrial ATP synthesis. This process might be
considered as compensatory ATP generation [16]. However, the gly-
colysis inhibition by 2DG indicated that the capacity to generate
ATP through glycolysis was more important in Oct1 −/− MEF cells
than in wild-type cells (36.61±2.58% and 32.06±2.78% respectively,
Pb0.01).
We pursued the MFP approach in order to obtain the detailed up-
take/secretion values (supplemental Table 3). The uptake of BCAAs
was signiﬁcantly increased in wild-type Oct1 cells compared to Oct1
deﬁcient cells (Fig. 9). Interestingly, we observed signiﬁcant increase
in the uptake of aspartate and of hydroxylysine, two amino acids in-
volved in the formation of TCA cycle substrates in wild-type Oct1
cells compared to that in Oct1−/− cells. Furthermore, the uptake of
γ-amino-N-butyric acid was increased in Oct1−/− cells compared to
that in the wild-types cells. However, secretions of lysine, alanine,
phosphoethanolamine, β-alanine, α-amino adipic acid, β-amino
isobutyric acid and ornithine were signiﬁcantly higher in Oct1 WT
cells compared to that in Oct1−/− cells. This indicates that Oct1 is in-
volved in upregulation of secretion of these amino acids. Oct1 inhibi-
tion induced a decrease in the uptake of all essential amino acids
except in valine with fold changes between 0.43 and 0.60 compared
to the wild-type MEFs (Fig. 9). The uptake of histidine, threonine, me-
thionine, phenylalanine, tryptophan, taurine, carnosine, anserine,
ethanolamine, citrulline, asparagine, serine, glutamine, arginine and
tyrosine and the secretion of alanine were signiﬁcantly increased in
the wild-type Oct1 cells compared to that in Oct1 deﬁcient cells.
Taken together, our metabolic proﬁle data suggest that Oct1 pro-
motes protein synthesis and stimulates the TCA cycle. The speciﬁc
MFP proﬁle of Oct1−/− cells is given in supplemental Fig. 2.
3.4. Oncosecretomics and biomarkers
Data on 12 to 15 samples of measurements for each of the forty
amino acids for each oncogene were analyzed via partial least squares
discriminant analysis to determine the groups of amino acids that are
responsible for best separating the wild-type and deﬁcient cells for
c-Myc, Oct1 or even KLF4. All samples with over 50% missing mea-
surements were removed, the data was standardized and remaining
missing values were imputed via ﬁve-nearest neighbors [17]. For
Fig. 6. Effect of KLF4 expression on glycolytic metabolites, mitochondrial respiration and energy production. The glucose consumption (A), the lactate secretion (B) and the pyruvate up-
take (C) were measured in MEFs. Each metabolite was measured after 24 h of incubation in high glucose DMEM (25 mM glucose) as growth media. The corresponding cell pellets were
used for quantifying the protein content for normalization. The results are expressed in μmol/μg protein asmean±S.E.M for the glucose, lactate and pyruvate content (*, Pb0.05; **, Pb0.01
and ***, Pb0.001). The oxygen consumption rate (OCR) has been measured in high glucose DMEM (HG, 25 mM glucose, 1 mM pyruvate and 4 mM glutamine) under endogenous con-
dition or in the presence of FCCP (2.5 μM) on the KLF4 wild-type, KLF4 +/− and KLF4 −/− cells (D). The OCR values expressed in pmol/min represent means±S.E.M (*, Pb0.05). The RCR
has also been determined (E). Then, the quantity of ATP produced by the wild-type, KLF4 +/− and KLF4 −/− cells (F) were determined in DMEM HG medium in presence of oligomycin
(2.5 μg/μl) and/or 2DG (100 mM). Data is expressed for each cell type in percent of ATP content without inhibitor as the mean±S.E.M (*, Pb0.05; **, Pb0.01 and ***, Pb0.001).
2067N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071each of the pairs of comparison factors, partial least squares
discriminant analysis was performed [18]. Results of this method
forclassifying samples between wild-type and knockout are given in
supplemental Table 4. Training misclassiﬁcation errors are given
using all the samples and testing errors are estimated by employing
leave one out cross-validation. In Fig. 10, scatterplots of the ﬁrst two
PLS component loadings are given illustrating the clusters of amino
acids that contribute to classifying between wild-type and c-Myc,Fo
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Fig. 7. Effect of KLF4 expression on metabolomics. The secretion of essentials, nones-
sentials and secondary amino acids were measured on MEF cells after 24 hour incuba-
tion in growth media. The amino acid secretion and uptake are expressed in fold
changes of the wild-type relative to KLF4 −/− (A) (*, Pb0.05; **, Pb0.01 and Pb0.001).KLF4 and Oct1 deﬁcient cells. Groups of amino acids from these
scatterplots reveal signiﬁcant patterns that well separate the two
classes. Thus, among all the amino acids identiﬁed, isoleucine could
be considered as a biomarker related to c-Myc expression. Isoleucine
is a precursor of acetyl-CoA and succinyl-CoA, intermediary of the
TCA cycle. Importantly, the increased isoleucine uptake induced by
c-Myc could explain the increase in RCR observed in TGR-1 and
HOMYC cells. For KLF4, α-aminoadipic acid is the metabolite that dis-
tinguishes the wild-type and deﬁcient cells. As mentioned previously,
AADA can lead to the production of acetyl-CoA which seems to induce
fatty acid synthesis instead of providing substrates for mitochondria.
Lastly, we found that γ-Amino-N-butyric acid (GABA) ﬂux is correlat-
ed with Oct1 expression. The increased consumption of GABA, a pre-
cursor of succinate, stimulates the TCA cycle, and thus may explain
the better efﬁciency of mitochondrial respiration for ATP production
in the MEF Oct1−/− compared to the wild-type as observed in our
results.
4. Discussion
The fundamental objective of this work was to assess in parallel
the bioenergetic and the secretomic impact of three oncogenes in
order to evaluate the predictive potential of metabolic footprinting.
The secondary aim was to reveal patterns of interest for cancer diag-
nosis and follow-up. The three oncogenes selected, c-Myc, KLF4 and
Oct1 were chosen for their recognized implication in carcinogenesis
but also for their recently described participation in cell differentia-
tion and the generation of induced pluripotent stem cells [19,20].
Previous biochemical studies indicate that c-Myc is not only
overexpressed in several tumors but also that its overall impact on
bioenergetics is complex. Indeed, c-Myc can activate the expression
Fig. 8. Effect of Oct1 expression on metabolomic, mitochondrial respiration and energy production. The glucose consumption (A), the lactate secretion (B) and the pyruvate uptake
(C) were measured in MEFs. Each metabolite was measured after 24 h of incubation of the MEF Oct1 wild-type and MEF Oct1 −/− cells, in high glucose DMEM (25 mM glucose) as
growth media. The corresponding cell pellets were used the protein content measurement for normalization. The results are expressed in μmol/μg protein as mean±S.E.M for the
glucose, lactate and pyruvate contents (*, Pb0.05; **, Pb0.01 and ***, Pb0.001). The oxygen consumption rate (OCR) has been measured in high glucose DMEM under endogenous
condition or in the presence of FCCP (2.5 μM) on the MEF Oct1 wild-type and Oct1 −/− cells (D). The OCR values expressed in pmol/min represent means±S.E.M (*, Pb0.05). The
RCR has also been determined (E). Then, the quantity of ATP produced by the wild-type and Oct1 −/− cells (F) were determined in DMEM HG medium in presence of oligomycin
(2.5 μg/μl) and/or 2DG (100 mM). Data is expressed for each cell type in percent of ATP content without inhibitor as the mean±S.E.M (*, Pb0.05; **, Pb0.01 and ***, Pb0.001).
2068 N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071of key glycolytic enzymes and also stimulate the uptake and the oxi-
dation of glutamine by the OXPHOS system [21,22]. c-Myc was fur-
ther shown to stimulate mitochondrial biogenesis [23] and thus
could be considered as a master regulator of energy metabolism.
We ﬁrst characterized the c-Myc induced changes in cell metabolism
by measuring the uptake of glucose and pyruvate concomitantly with
lactate secretion. The glucose uptake and the lactate secretion are the
two parameters, which deﬁne the Warburg effect [24,25]. In our
study, the high glucose uptake observed in c-Myc deﬁcient cells isFo
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Fig. 9. Effect of Oct1 expression on metabolomic. The amino acid secretion and uptake
were quantiﬁed on MEF wild-type and Oct1−/− after 24 h of incubation. The results are
expressed in fold changes of the wild-type relative to Oct1 −/− (A) (*, Pb0.05; **,
Pb0.01 and Pb0.001).consistent with the bioenergetic remodeling described in induced
pluripotent stem cells (iPSC) where c-Myc expression was inhibited
[12] and in cMycCHO cells expressing c-Myc, characterized by a glu-
cose consumption and a lactate secretion decreased [13]. The mea-
surements performed led us initially to the conclusion that c-Myc
deﬁciency induces theWarburg effect. It is known that c-Myc induces
the stimulation of glycolysis by increasing the expression of different
enzymes, including glucose transporter (GLUT1), LDH-A [21] and py-
ruvate kinase M2 (PKM2) which is a strongly controlling step of gly-
colysis (see [26] for review). To verify this point, we analyzed PKM2
expression by western blot and found a higher content of this protein
in TGR-1 and HOMYC cells (active c-Myc) as compared to HO15 cells
(inactive c-Myc). Furthermore, we speciﬁed some features of c-Myc
activation as we found that in addition to the above mentioned effect
of c-Myc on glycolysis, this oncogene stimulates mitochondrial ATP
production and thereby enhances the respiratory coupling ratio. Ac-
cordingly, our secretomic analysis shows that the observed higher ef-
ﬁciency of the OXPHOS system in c-Myc expressing cells might result
from the increased consumption of isoleucine which is a precursor of
various anaplerotic substrates [27]. Likewise, lysine and leucine can
also be converted to acetoacetyl-CoA and then enter the TCA cycle
through acetyl-CoA [28,29]. Our ﬁndings might suggest that c-Myc's
pro-oxidative effect is not restricted to glutamine [15] and could
also concern lysine and leucine, both of which can generate acetyl-
coA and enter the Krebs cycle for complete catabolism. Furthermore,
a recent study showed that supplementation of three BCAAs: leucine,
isoleucine, and valine supported mitochondrial biogenesis in cardiac
and skeletal muscle [30] and c-Myc expression has been previously
associated with increased mitochondrial biogenesis [23]. Lastly,
according to the proﬁle generated with the MFP approach, we provid-
ed evidence that c-Myc proﬁcient cells had higher taurine secretion
compared to c-Myc deﬁcient cells. This metabolite has been implicat-
ed in the regulation of cell volume and was found to be upregulated in
Fig. 10. Partial least squares discriminant scatterplots of amino acids related to oncogene expression. The key metabolites that discriminate TGR-1 (A) or HOMYC (B) with HO15
cells are circled in green. But the amino acids attributed to c-Myc expression, as well as the biomarkers revealed when comparing KLF4 (C) and Oct1 (D) deﬁcient cells with
their respective control, are circled in red.
2069N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071squamous cell carcinoma [31]. We observed a higher alanine uptake
in TGR-1 and HOMYC cells compared to HO15 cells. The alanine up-
take can lead to the production of pyruvate and provide substrates
such as NADH for the OXPHOS system. Hence, c-Myc might be re-
sponsible for stimulating mitochondrial function by modulating the
consumption of alanine. The pyruvate consumption remained the
same after the re-expression of c-Myc in HOMYC cells as compared
to HO15. This ﬁnding is consistent with the analysis of mitochondrial
respiration measured under both endogenous condition and in the
presence of FCCP. c-Myc in HOMYC cells failed to reestablish an OCR
similar to the one measured in TGR-1 cells. Furthermore, the maximal
respiration measured with the uncoupler FCCP indicated an identical
respiratory capacity in HO15 and HOMYC cells. The similar pyruvate
uptake in HOMYC and HO15 cells might be explained by an identical
PDH activity in both cell lines. Previous studies with NMR experi-
ments by using 13C-pyruvate demonstrated that endogenous c-Myc
increases PDH activity in ﬁbroblasts [32]. However, pyruvate carbox-
ylase expression was increased in c-Myc −/− cells compared to the
c-Myc +/+ cells. Hence, difference in the pyruvate ﬂuxes between
those TGR-1 and HOMYC cells could be explained by the endogenous
expression of c-Myc in TGR-1 cells and its exogenous expression in
HOMYC which might not lead to the upregulation of PDH.
The second candidate that we considered for our combined analy-
sis of secretomics and bioenergetics was KLF4. KLF4 is a transcription
factor which was previously described as a tumor suppressor in lung
and colon cancer [33–35], but also as an oncogene required for cell
migration and invasion in breast cancer [36]. Little is known on the
bioenergetics impact of this factor and we here found that KLF4 sup-
pression triggers the Warburg effect. In contrast with c-Myc oncogen-
ic inhibition in HO15 cells which reduced the respiratory capacity
of the cells, KLF4 had no effect on oxygen consumption. Regardingsecretomics, we identiﬁed an increase in AADA secretion which
could be attributed to deregulation of fatty acid synthesis triggered
by KLF4 inhibition. Our hypothesis is based on the observations that
KO of KLF4 had no effect on mitochondrial respiration and ATP pro-
duction. AADA is also considered as a glutamate analogue and pro-
motes the proliferation of glial cells [37]. Given the negative
correlation of KLF4 expression with cell proliferation, the important
AADA secretion observed in KLF4 deﬁcient cells might be because of
lysine metabolism that contributes to the synthesis of acetyl-CoA
probably for membrane synthesis necessary for cell growth. It will
be relevant to study AADA ﬂuxes on human cancer cells in order to
consider the modulation of its production as a therapeutic strategy
for cancer treatment. As compared to the oncogenes c-Myc and
Oct1, KLF4 appears to play a role less important in cell metabolism.
We observed an enhancement of glycolysis in the KLF4 deﬁcient
cells based on the increase of glucose uptake and lactate secretion.
The enhancement of glycolytic phenotype observed in the KLF4−/−
cells is consistent with the Warburg effect, which is a characteristic
of proliferative cells. In addition, KLF4 expression has been reported
to be decreased during the exponential phase of cell proliferation
[38]. Furthermore, we provide evidence regarding KLF4 and its impli-
cation to the mitochondrial function with a similar RCR and identical
ATP production capacity when comparing the wild type and the
KLF4−/− cells. The metabolic signature observed in KLF4 deﬁcient
cells suggested an increase in protein synthesis probably necessary
for proliferative cells. For example, the signiﬁcant increase in hy-
droxyproline uptake observed might be required for collagen synthe-
sis, criterion usually observed in ﬁbroblasts localized in tumor
microenvironment.
The third candidate was the Octamer transcription factor 1 (Oct1),
a ubiquitous member of the POU-homeodomain family that functions
2070 N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071as a coregulator of the androgen receptor. Oct1 expression is in-
creased in gastric carcinomas and lung adenocarcinomas [39,40].
We found that Oct1 deﬁciency leads to a reduced glycolytic pheno-
type with an inhibition of pyruvate uptake but increases the efﬁcien-
cy of the OXPHOS system. Therefore, the three analyzed oncogenes
trigger speciﬁc bioenergetic changes that could explain in part the
variability of the bioenergetics proﬁle observed in tumors. We de-
ﬁned GABA as biomarker of Oct1 expression. The increase of GABA
uptake, precursor of succinate, can explain the higher efﬁciency of
mitochondrial respiration of Oct1 deﬁcient cells as compare to the
wild-type. The intracellular content of succinate among other TCA
cycle intermediates has been reported to be decreased in Oct1 ex-
pressing cells [8]. Hence, the bioenergetics proﬁle indicates that
Oct1 expression reduces the uptake of GABA which leads to decrease
in anaplerotic substrates content. The metabolic remodeling observed
in Oct1 deﬁcient cells was different from the other two oncogenes
KLF4 and c-Myc. The inhibition of Oct1 expression in the MEFs was
correlated with a decrease in glucose consumption and lactate secre-
tion. Our results conﬁrmed that the pyruvate uptake was also de-
creased in Oct1−/− cells compared to the wild-type MEFs. Oct1 is
responsible for the regulation of pyruvate uptake and even oxidation,
as well as most of the essential amino acids. The fact that Oct1 deﬁ-
ciency leads to an increase in RCR is in accordance with the higher mi-
tochondrial capacity for ATP production as observed in our results.
Shakaya et al. reported in their study that Oct1 deﬁciency induced
metabolic changes which are consistent with a noncancer pheno-
types because Oct1 inhibition by shRNA was responsible for a signif-
icant reduction in tumor forming potential of A549 cells in nude
mice [8]. In summary, we can conclude that Oct1 expression is not
only correlated with the Warburg effect, but also with a reduced
OXPHOS efﬁciency.
In conclusion, we exempliﬁed the importance of secretomics in
the analysis of metabolic changes induced by oncogenes. c-Myc,
Oct1 and KLF4 which play a role in the cell metabolism, regulate the
energy state of the cells at different level. The MFP approach used in
this study, permitted to highlight key metabolites such as isoleucine,
AADA and GABA, for which the concentrations were correlated with
both oncogene expression and cellular bioenergetic signatures. Our
results suggest that this method when applied to tumors and their re-
spective plasma could reveal biomarkers associated with energy met-
abolic changes in carcinogenesis. As a ﬁrst step of cancer cells
metabolic evaluation, we measured the uptake of glucose and pyru-
vate concomitantly with lactate secretion. Glucose consumption is
widely used for tumor detection by PET scan (Positron Emission To-
mography) which supports the importance of developing and reﬁn-
ing secretomic analysis for cancer diagnosis. Hence, oncosecretomics
could help in cancer diagnosis and provide information on the meta-
bolic changes that occur inside the tumor. Since, no data was yet
available on the potential interest of this methodology so we tested
it ﬁrst on the cell culture models that can be easily characterized
from the bioenergetics standpoint. Secretomics performed on cells
with variable expression of c-Myc, KLF4 and Oct1 allowed us to iden-
tify a set of new biomarkers: isoleucine, AADA and GABA. The uptake
and secretion of those amino acids varied speciﬁcally with the modu-
lation of oncogene expression and changed in correlation with the
bioenergetics impact of those oncogenes. Our study illustrates the in-
terest of secretomics for cancer biology and for the study of tumor
bioenergetics.
Acknowledgements
We thank Dr. Dean Tantin (University of Utah School of Medicine),
Dr John Sedivy (Brown University), Dr. Chi V. Dang (The Johns
Hopkins University School of Medicine) and Dr. Vincent Yang
(Emory University School of Medicine) for providing the cell lines in
this study. This work was supported by funding from Rice University.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbabio.2012.07.004.References
[1] N. Bellance, P. Lestienne, R. Rossignol, Mitochondria: from bioenergetics to the
metabolic regulation of carcinogenesis, Front. Biosci. 14 (2009) 4015–4034.
[2] C. Jose, N. Bellance, R. Rossignol, Choosing between glycolysis and oxidative
phosphorylation: a tumor's dilemma? Biochim. Biophys. Acta 1807 (2011)
552–561.
[3] D. Nagrath, C. Caneba, T. Karedath, N. Bellance, Metabolomics for mitochondrial
and cancer studies, Biochim. Biophys. Acta 1807 (2011) 650–663.
[4] T.J. Wang, M.G. Larson, R.S. Vasan, S. Cheng, E.P. Rhee, E. McCabe, G.D. Lewis, C.S.
Fox, P.F. Jacques, C. Fernandez, C.J. O'Donnell, S.A. Carr, V.K. Mootha, J.C. Florez, A.
Souza, O. Melander, C.B. Clish, R.E. Gerszten, Metabolite proﬁles and the risk of
developing diabetes, Nat. Med. 17 (2011) 448–453.
[5] E.S. Ong, L. Zou, S. Li, P.Y. Cheah, K.W. Eu, C.N. Ong, Metabolic proﬁling in colorec-
tal cancer reveals signaturemetabolic shifts during tumorigenesis,Mol. Cell.
Proteomics (in press).
[6] A. Sreekumar, L.M. Poisson, T.M. Rajendiran, A.P. Khan, Q. Cao, J. Yu, B. Laxman, R.
Mehra, R.J. Lonigro, Y. Li, M.K. Nyati, A. Ahsan, S. Kalyana-Sundaram, B. Han, X.
Cao, J. Byun, G.S. Omenn, D. Ghosh, S. Pennathur, D.C. Alexander, A. Berger, J.R.
Shuster, J.T. Wei, S. Varambally, C. Beecher, A.M. Chinnaiyan, Metabolomic pro-
ﬁles delineate potential role for sarcosine in prostate cancer progression, Nature
457 (2009) 910–914.
[7] M.K. Mateyak, A.J. Obaya, S. Adachi, J.M. Sedivy, Phenotypes of c-Myc-deﬁcient rat
ﬁbroblasts isolated by targeted homologous recombination, Cell Growth Differ.
8 (1997) 1039–1048.
[8] A. Shakya, R. Cooksey, J.E. Cox, V. Wang, D.A. McClain, D. Tantin, Oct1 loss of func-
tion induces a coordinate metabolic shift that opposes tumorigenicity, Nat. Cell
Biol. 11 (2009) 320–327.
[9] E.G. Hagos, A.M. Ghaleb, W.B. Dalton, A.B. Bialkowska, V.W. Yang, Mouse embryonic
ﬁbroblasts null for the Kruppel-like factor 4 gene are genetically unstable, Oncogene
28 (2009) 1197–1205.
[10] R.C. O'Hagan, M. Ohh, G. David, I.M. de Alboran, F.W. Alt, W.G. Kaelin Jr., R.A.
DePinho, Myc-enhanced expression of Cul1 promotes ubiquitin-dependent pro-
teolysis and cell cycle progression, Genes Dev. 14 (2000) 2185–2191.
[11] D. Kuystermans, M. Al-Rubeai, cMyc increases cell number through uncoupling of
cell division from cell size in CHO cells, BMC Biotechnol. 9 (2009) 76.
[12] C.D. Folmes, T.J. Nelson, A. Martinez-Fernandez, D.K. Arrell, J.Z. Lindor, P.P. Dzeja,
Y. Ikeda, C. Perez-Terzic, A. Terzic, Somatic oxidative bioenergetics transitions
into pluripotency-dependent glycolysis to facilitate nuclear reprogramming,
Cell Metab. 14 (2011) 264–271.
[13] D. Kuystermans, M.J. Dunn, M. Al-Rubeai, A proteomic study of cMyc improvement
of CHO culture, BMC Biotechnol. 10 (2010) 25.
[14] N. Bellance, G. Benard, F. Furt, H. Begueret, K. Smolkova, E. Passerieux, J.P. Delage,
J.M. Baste, P. Moreau, R. Rossignol, Bioenergetics of lung tumors: alteration of mi-
tochondrial biogenesis and respiratory capacity, Int. J. Biochem. Cell Biol. 41
(2009) 2566–2577.
[15] D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, H.K. Pfeiffer, I.
Nissim, E. Daikhin, M. Yudkoff, S.B. McMahon, C.B. Thompson, Myc regulates a
transcriptional program that stimulates mitochondrial glutaminolysis and leads
to glutamine addiction, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 18782–18787.
[16] W. Qian, B. VanHouten, Alterations in bioenergetics due to changes inmitochondrial
DNA copy number, Methods 51 (2010) 452–457.
[17] O. Troyanskaya, M. Cantor, G. Sherlock, P. Brown, T. Hastie, R. Tibshirani, D.
Botstein, R.B. Altman, Missing value estimation methods for DNA microarrays,
Bioinformatics 17 (2001) 520–525.
[18] M. Barker, W. Rayens, Partial least squares for discrimination, J. Chemometr. 17
(2003) 166–173.
[19] K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse
embryonic and adult ﬁbroblast cultures by deﬁned factors, Cell 126 (2006)
663–676.
[20] S. Yamanaka, K. Takahashi, Induction of pluripotent stem cells from mouse ﬁbro-
blast cultures, Tanpakushitsu Kakusan Koso 51 (2006) 2346–2351.
[21] H. Shim, C. Dolde, B.C. Lewis, C.S. Wu, G. Dang, R.A. Jungmann, R. Dalla-Favera,
C.V. Dang, c-Myc transactivation of LDH-A: implications for tumor metabolism
and growth, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6658–6663.
[22] M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, Y. Lazebnik, Deﬁciency in
glutamine but not glucose induces MYC-dependent apoptosis in human cells,
J. Cell Biol. 178 (2007) 93–105.
[23] F. Li, Y. Wang, K.I. Zeller, J.J. Potter, D.R. Wonsey, K.A. O'Donnell, J.W. Kim, J.T.
Yustein, L.A. Lee, C.V. Dang, Myc stimulates nuclearly encoded mitochondrial
genes and mitochondrial biogenesis, Mol. Cell. Biol. 25 (2005) 6225–6234.
[24] O. Warburg, F. Wind, E. Negelein, The metabolism of tumors in the body, J. Gen.
Physiol. 8 (1927) 519–530.
[25] O. Warburg, On the origin of cancer cells, Science 123 (1956) 309–314.
[26] C.V. Dang, A. Le, P. Gao,MYC-induced cancer cell energymetabolism and therapeutic
opportunities, Clin. Cancer Res. 15 (2009) 6479–6483.
[27] M.L. Johansen, L.K. Bak, A. Schousboe, P. Iversen, M. Sorensen, S. Keiding, H.
Vilstrup, A. Gjedde, P. Ott, H.S. Waagepetersen, The metabolic role of isoleucine
2071N. Bellance et al. / Biochimica et Biophysica Acta 1817 (2012) 2060–2071in detoxiﬁcation of ammonia in cultured mouse neurons and astrocytes,
Neurochem. Int. 50 (2007) 1042–1051.
[28] D. Nagrath, M. Avila-Elchiver, F. Berthiaume, A.W. Tilles, A. Messac, M.L. Yarmush,
Soft constraints-based multiobjective framework for ﬂux balance analysis, Metab.
Eng. 12 (2010) 429–445.
[29] D. Nagrath, M. Avila-Elchiver, F. Berthiaume, A.W. Tilles, A. Messac, M.L. Yarmush,
Integrated energy and ﬂux balance based multiobjective framework for large-scale
metabolic networks, Ann. Biomed. Eng. 35 (2007) 863–885.
[30] G. D'Antona, M. Ragni, A. Cardile, L. Tedesco, M. Dossena, F. Bruttini, F. Caliaro,
G. Corsetti, R. Bottinelli, M.O. Carruba, A. Valerio, E. Nisoli, Branched-chain
amino acid supplementation promotes survival and supports cardiac and skeletal
muscle mitochondrial biogenesis in middle-aged mice, Cell Metab. 12 (2010)
362–372.
[31] S. El-Sayed, T. Bezabeh, O. Odlum, R. Patel, S. Ahing, K. MacDonald, R.L. Somorjai,
I.C. Smith, An ex vivo study exploring the diagnostic potential of 1H magnetic reso-
nance spectroscopy in squamous cell carcinoma of the head and neck region, Head
Neck 24 (2002) 766–772.
[32] F. Morrish, N. Isern, M. Sadilek, M. Jeffrey, D.M. Hockenbery, c-Myc activates mul-
tiple metabolic networks to generate substrates for cell-cycle entry, Oncogene 28
(2009) 2485–2491.
[33] Y. Zhou, W.L. Hofstetter, Y. He, W. Hu, A. Pataer, L. Wang, J. Wang, L. Yu, B. Fang,
S.G. Swisher, KLF4 inhibition of lung cancer cell invasion by suppression of SPARC
expression, Cancer Biol. Ther. 9 (2010) 507–513.[34] Z.Y. Chen, J.L. Shie, C.C. Tseng, Gut-enriched Kruppel-like factor represses ornithine
decarboxylase gene expression and functions as checkpoint regulator in colonic
cancer cells, J. Biol. Chem. 277 (2002) 46831–46839.
[35] D.T. Dang, X. Chen, J. Feng, M. Torbenson, L.H. Dang, V.W. Yang, Overexpression of
Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced
tumorigenecity, Oncogene 22 (2003) 3424–3430.
[36] F. Yu, J. Li, H. Chen, J. Fu, S. Ray, S. Huang, H. Zheng, W. Ai, Kruppel-like factor 4
(KLF4) is required for maintenance of breast cancer stem cells and for cell migra-
tion and invasion, Oncogene 30 (2011) 2161–2172.
[37] M. Takeda, A. Takamiya, J.W. Jiao, K.S. Cho, S.G. Trevino, T. Matsuda, D.F. Chen,
alpha-Aminoadipate induces progenitor cell properties of Muller glia in adult
mice, Invest. Ophthalmol. Vis. Sci. 49 (2008) 1142–1150.
[38] X. Chen, D.C. Johns, D.E. Geiman, E. Marban, D.T. Dang, G. Hamlin, R. Sun, V.W.
Yang, Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell prolif-
eration by blocking G1/S progression of the cell cycle, J. Biol. Chem. 276 (2001)
30423–30428.
[39] R. Almeida, J. Almeida, M. Shoshkes, N. Mendes, P. Mesquita, E. Silva, I. Van Seuningen,
C.A. Reis, F. Santos-Silva, L. David, OCT-1 is over-expressed in intestinal metaplasia and
intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric
cells, J. Pathol. 207 (2005) 396–401.
[40] S. Reymann, J. Borlak, Transcription proﬁling of lung adenocarcinomas of
c-myc-transgenic mice: identiﬁcation of the c-myc regulatory gene network,
BMC Syst. Biol. 2 (2008) 46.
